Carbamazepine-induced hypersensitivity pneumonitis in a patient with neuromyelitis optica: A case report
Indian J Physiol Pharmacol
;
2022 Mar; 66(1): 81-83
Artículo
| IMSEAR
| ID: sea-223995
ABSTRACT
A 36-year-old female with serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) on carbamazepine (CBZ) therapy for paroxysmal tonic spasms (PTS) developed Type 1 respiratory failure. High-resolution computed tomography chest showed diffuse ground-glass opacities in both lungs predominantly in bilateral perihilar region sparing subpleural regions and predominantly upper lobes with a smooth interlobular septal thickening. A transbronchial lung biopsy was consistent with hypersensitivity pneumonitis and following withdrawal of the CBZ and treatment with steroids her respiratory symptoms resolved. After stopping CBZ, PTS recurred, which was successfully treated with lacosamide. This is the first described biopsy-proven case of CBZ-induced hypersensitivity pneumonitis in the NMOSD patient.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Revista:
Indian J Physiol Pharmacol
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS